ACT-672125
Product Specifications
Target
Others|||CXCR
Related Pathways
Autophagy|||Immunology/Inflammation|||GPCR/G Protein|||Others
Bioactivity
ACT-672125 is a Potent CXCR3 Antagonist with Therapeutic Potential in Autoimmune Diseases. ACT-672125 showed good physicochemical properties and safety profile. In a proof-of-mechanism model of lung inflammation, ACT-672125 inhibited the recruitment of CXCR3 expressing T cells into the inflamed lung in a dose-dependent manner.
Smiles
C(F)(F)(F)C1=NC(=C(S1)N2C[C@@H](C)N(C(CN3C(C)=NC(C)=N3)=O)CC2)C=4NC=5C(N4)=CC=C(C5)C6=NOC(C)=N6
Molecular Formula
C25H25F3N10O2S
Molecular Weight
586.59
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/B19B7F09-CC74-49AB-9B0E-CE9F2BD432B4/T70616
CAS Number
1449367-94-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal Enolase 2/Neuron-specific Enolase Antibody (NSEP1) [DyLight 405]](https://cdn.genprice.uk/genprice/genprice3.png)
NBP2-50532V 0.1 mL
Mouse Monoclonal Enolase 2/Neuron-specific Enolase Antibody (NSEP1) [DyLight 405]
Ask
View Details 
